Patents by Inventor Nae Yoo

Nae Yoo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for treatment of wounds containing blood plasma or serum
    Publication number: 20070148142
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of wounds containing blood plasma or serum and a method for treating wounds effectively by applying said composition to the wound site to normalize the tissue-environment around the site.
    Type: Application
    Filed: December 12, 2006
    Publication date: June 28, 2007
    Inventors: Won Yoo, Kyung Chang, Nae Yoo, Ki Keum, Sang Lee, Gene Lee
  • Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
    Publication number: 20050266430
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Application
    Filed: February 16, 2005
    Publication date: December 1, 2005
    Inventors: Sang Lee, Nae Yoo, So Yoo, Hyun Chung, Ki Keum, Won Yoo, Ki Jeong
  • Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
    Publication number: 20050244856
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Application
    Filed: February 16, 2005
    Publication date: November 3, 2005
    Inventors: Sang Lee, Nae Yoo, So Yoo, Hyun Chung, Ki Keum, Won Yoo, Ki Jeong
  • Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
    Publication number: 20050170416
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Application
    Filed: February 16, 2005
    Publication date: August 4, 2005
    Inventors: Sang Lee, Nae Yoo, So Yoo, Hyun Chung, Ki Keum, Won Yoo, Ki Jeong
  • Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
    Publication number: 20050170417
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Application
    Filed: February 16, 2005
    Publication date: August 4, 2005
    Inventors: Sang Lee, Nae Yoo, So Yoo, Hyun Chung, Ki Keum, Won Yoo, Ki Jeong
  • Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3
    Publication number: 20050158810
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Application
    Filed: February 16, 2005
    Publication date: July 21, 2005
    Inventors: Sang Lee, Nae Yoo, So Yoo, Hyun Chung, Ki Keum, Won Yoo, Ki Jeong
  • Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
    Publication number: 20050142208
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of wounds containing blood plasma or serum and a method for treating wounds effectively by applying said composition to the wound site to normalize the tissue-environment around the site.
    Type: Application
    Filed: May 9, 2003
    Publication date: June 30, 2005
    Inventors: Won Min Yoo, Kyung Chang, Nae Yoo, Ki Keum, Sang Lee, Gene Lee
  • Interleukin-2 gene transferred lymphokine activated killer cells
    Publication number: 20050095230
    Abstract: The present invention relates to a transformed lymphokine activated killer cell (I-LAK cell) useful in the treatment of cancer or virus infection into which a recombinant vector carrying IL-2 gene to which it is operably linked is introduced. Also it relates to a pharmaceutical composition for treating cancer or virus infection disease comprising a sufficient amount of I-LAK cell to elicit an immune response.
    Type: Application
    Filed: November 22, 2002
    Publication date: May 5, 2005
    Inventors: Nae Yoo, Kyung Chang, Yeon Kim, June Kim